| Project/Area Number |
24KF0157
|
|---|
| Research Category |
Grant-in-Aid for JSPS Fellows
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 外国 |
|---|
| Review Section |
Basic Section 90110:Biomedical engineering-related
|
|---|
| Research Institution | Kyoto University |
|---|
Principal Investigator |
堀田 秋津 京都大学, iPS細胞研究所, 准教授 (50578002)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
HU HOOI TING 京都大学, iPS細胞研究所, 外国人特別研究員
|
|---|
| Project Period (FY) |
2024-10-01 – 2027-03-31
|
| Project Status |
Granted (Fiscal Year 2024)
|
| Budget Amount *help |
¥2,000,000 (Direct Cost: ¥2,000,000)
Fiscal Year 2026: ¥300,000 (Direct Cost: ¥300,000)
Fiscal Year 2025: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2024: ¥500,000 (Direct Cost: ¥500,000)
|
|---|
| Outline of Research at the Start |
CRISPR-Cas genome editing therapy offers promise for treating genetic disorders, but viral delivery methods often trigger immune responses. Our goal is to create genome-editing vesicles with fewer side effects yet high delivery efficiency by engineering the NanoMEDIC delivery system.
|
